Enzo Biochem 13D Filing From Harbert Fund Advisors Shows Unchanged 11.74% Stake; Includes 'Purpose Of Transaction' Fund 'sent a letter to the Board of the Issuer calling for the immediate resignation of Elazar Rabbani, the Chairman of the Board and CEO'